Redeye saw a sales performance in the quarter that did not meet our high expectations but still showed a healthy organic growth of 20%. We assess that the 1-2 orders we expected did not materialize in the quarter, explaining some deviations. In light of the weaker outcome and somewhat more uncertain short-term development during the coming two quarters, we decrease our Base Case to SEK 100 (115) per share with a fair value range of 55 (60) to 175 (195) per share. We are still firm believers in the long-term growth case, and it is improbable that Telia will not place an order during 2023e.

Read more and download the Research Update.

Follow companies at Redeye to receive the latest equity research within Life Science and Technology.

This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/

Attachments

Waystream - Potential still present

© Modular Finance, source Nordic Press Releases